Moderna Inc.

The momentum for this stock is not very good. Moderna Inc. is not a good value stock. Moderna Inc. is not a good growth stock. Moderna Inc. is not very popular among insiders. Moderna Inc. is a mediocre stock to choose.
Log in to see more information.
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic...

News

Wall St Indexes Rise Even With Smaller Rate Cut in View
Wall St Indexes Rise Even With Smaller Rate Cut in View

Newsmax Finance - Street Talk Wall Street's main indexes rose on Thursday after higher-than-expected producer prices data reinforced expectations for a 25-basis point rate cut by the Federal Reserve, while Moderna slumped...\n more…

3-Stock Lunch: Moderna, Delta Air Lines
3-Stock Lunch: Moderna, Delta Air Lines

CNBC Television-YouTube 3-Stock Lunch: Moderna, Delta Air Lines...\n more…

Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans

Fast Company With the pandemic in the past, the Cambridge-based biotech company has struggled to maintain success, now announcing it will cut 20% of its R&D budget by 2027.\n\nModerna (NYSE: MRNA) stock plunged...\n more…

Moderna cites 2025 launch for Merck partnered cancer vaccine: report
Moderna cites 2025 launch for Merck partnered cancer vaccine: report

Seeking Alpha - Healthcare Moderna cites 2025 launch for Merck partnered cancer vaccine: report...\n more…

Moderna to launch skin cancer vaccine as soon as 2025: CEO
Moderna to launch skin cancer vaccine as soon as 2025: CEO

Nikkei Asian Review Moderna to launch skin cancer vaccine as soon as 2025: CEO...\n more…

FIVE at FIVE: Lloyds up on Basel rules; Moderna tanks; FTSE 100 gains; House prices surprise; Scottish Mortgage Nvidia boost
FIVE at FIVE: Lloyds up on Basel rules; Moderna tanks; FTSE 100 gains; House prices surprise; Scottish Mortgage Nvidia boost

Proactive Investors - UK FIVE at FIVE: Lloyds up on Basel rules; Moderna tanks; FTSE 100 gains; House prices surprise; Scottish Mortgage Nvidia boost...\n more…